Idiopathic restrictive cardiomyopathy in children is caused by mutations in cardiac sarcomere protein genes

@article{Kaski2007IdiopathicRC,
  title={Idiopathic restrictive cardiomyopathy in children is caused by mutations in cardiac sarcomere protein genes},
  author={Juan Pablo Kaski and Petros Syrris and Michael Burch and Mar{\'i}a Teresa Tom{\'e}-Esteban and Matthew J Fenton and Michael Christiansen and Paal Skytt Andersen and Neil James Sebire and Michael T. Ashworth and John Erik Deanfield and William J. McKenna and Perry M. Elliott},
  journal={Heart},
  year={2007},
  volume={94},
  pages={1478 - 1484}
}
Background: Restrictive cardiomyopathy (RCM) is rare in childhood, but has a grave prognosis. The cause of disease in most cases is unknown. Objective: To determine the prevalence of sarcomere protein gene mutations in children with idiopathic RCM. Methods: Twelve patients (9 female, mean age 5.1 years) with idiopathic RCM referred between 1991 and August 2006 underwent detailed clinical and genetic evaluation. Nine had received cardiac transplants at the time of the study. The entire coding… 
View on BMJ
ncbi.nlm.nih.gov
194 Citations
Highly Influential Citations
7
Background Citations
47
Results Citations
1

194 Citations

Idiopathic restrictive cardiomyopathy - perspectives from genetics studies. Is it time to redefine these disorders?

H CM with restrictive physiology should be considered part of a continuous spectrum with IRC, because patients with HCM with restrictive phenotype bear far greater clinical and genetic resemblance to IRC than to rest of the HCM cohort.

Cardiomyopathy in Childhood: Histopathological and Genetic Features

The pathology of cardiomyopathy and the increasing number of genes involved in its aetiology and pathogenesis are detailed and genetic analysis provides prognostic information.

A Systematic Review of Phenotypic Features Associated With Cardiac Troponin I Mutations in Hereditary Cardiomyopathies.

Complexity of Sarcomere Protein Gene Mutations in Restrictive Cardiomyopathy

Advances in molecu ‐ lar genetics of cardiovascular diseases are unlikely to be sufficient to trigger a full switch from a phenotype‐based to genotyped‐based medicines, and a comprehensive understanding of molecular mechanism of the pathogenesis integrating the genetic, epigenetic, transcriptomic, and proteomic profiles is necessary.

A rare case of familial restrictive cardiomyopathy, with mutations in MYH7 and ABCC9 genes

The case of a 43-year-old patient diagnosed with familial restrictive cardiomyopathy with positive genetic tests for mutations of MYH7 gene and ABCC9 gene is discussed, which showed a continuous alteration of right ventricle function, without important differences of left ventricular function.

Malignant and benign mutations in familial cardiomyopathies: insights into mutations linked to complex cardiovascular phenotypes.

Clinical genetic testing in four highly suspected pediatric restrictive cardiomyopathy cases

The findings support the notion that genetic testing may be helpful in the clinical diagnosis of RCM and identify one novel heterozygous mutation in the TNNI3 gene in three of the four patients.

Restrictive cardiomyopathy

Recent reports suggest that mutations in sarcomeric contractile protein genes are not uncommon in RCM, implying that RCM may be hereditary, and that clinical assessment of relatives should be considered in addition to genetic investigations when systemic disease has been excluded.

Mutations in FLNC are Associated with Familial Restrictive Cardiomyopathy

FLNC is a disease gene for autosomal‐dominant RCM and broadens the phenotype spectrum of filaminopathies.

Evidence for troponin C (TNNC1) as a gene for autosomal recessive restrictive cardiomyopathy with fatal outcome in infancy

It is indicated that TNNC1 is a likely novel gene for autosomal recessive restrictive cardiomyopathy, a rare form of pediatric cardiac disease associated with septal hypertrophy and compound heterozygosity for TnnC1 mutations.
...

References

SHOWING 1-10 OF 44 REFERENCES

Idiopathic restrictive cardiomyopathy is part of the clinical expression of cardiac troponin I mutations.

A large family in which individuals were affected by either idiopathic RCM or hypertrophic cardiomyopathy was recognized, and linkage analysis to selected sarcomeric contractile protein genes identified cardiac troponin I (TNNI3) as the likely disease gene.

Novel Cardiac Troponin T Mutation as a Cause of Familial Dilated Cardiomyopathy

A novel missense mutation in the cardiac troponin T gene is identified by direct sequencing and confirmed by endonuclease restriction analysis in a large family with FDCM and appears that the phenotype, whether it be hypertrophy or dilatation, is determined by the specific mutation rather than the gene.

Hypertrophic Cardiomyopathy: Histopathological Features of Sudden Death in Cardiac Troponin T Disease

Restrictive cardiomyopathies in childhood. Etiologies and natural history.

In conclusion, restrictive cardiomyopathy in childhood is commonly idiopathic or associated with cardiac hypertrophy, and the prognosis is poor; therefore, transplantation should be considered early.

Clinical and molecular studies of a large family with desmin‐associated restrictive cardiomyopathy

Data support literature suggesting that desmin deposition may be associated with different underlying gene defects, and that a novel desminopathy gene is responsible for the condition in this family.

First description of germline mosaicism in familial hypertrophic cardiomyopathy

This is the first description of germline mosaicism shown by molecular genetic analysis in an autosomal dominant disorder and more especially in hypertrophic cardiomyopathy that had been inherited from the mother but did not affect her somatic cells.

Idiopathic restrictive cardiomyopathy in children

Without transplantation, most children with restrictive cardiomyopathy have a very poor prognosis and longer survival from diagnosis was correlated with lower LA:Ao and cardiac filling pressures at diagnosis.

Cardiomyopathy in children

  • Su-chiung Chen
  • Medicine
    Current treatment options in cardiovascular medicine
  • 2001
Maximal medical therapy with inotropic drugs or cardiac glycosides, diuretic drugs, and angiotensin-converting enzyme inhibitors improve heart failure symptoms in patients with DCM and RCM and anticoagulation to prevent thromboembolism is indicated.

Familial restrictive cardiomyopathy with atrioventricular block and skeletal myopathy.

Five generations of an Italian family with an autosomal dominant restrictive cardiomyopathy are described, characterised by normal ventricular size and systolic function with increased diastolic filling pressures in both ventricles and consequent bi-atrial enlargement.

Clinical profile and outcome of idiopathic restrictive cardiomyopathy.

Idiopathic restrictive cardiomyopathy or nondilated, nonhypertrophic ventricles with marked biatrial dilatation, as defined morphologically by echocardiography, affects predominantly elderly patients but can occur in any age group.